| J9271 | Injection, pembrolizumab, 1 mg | 8,800 | $40 | $308.1K |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase‑fihj | 5,940 | $40 | $225.7K |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 1,140 | $20 | $23.9K |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 1,070 | $20 | $22.5K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 220 | $100 | $22.4K |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 80 | $140 | $11.1K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community… | 40 | $210 | $8.6K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 40 | $140 | $5.7K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 90 | $60 | $5K |
| 96375 | Following the administration of a drug or other substance via intravenous, or IV, push, the provider sequentially infuses a different medication or medications, also via IV push. He administers the… | 300 | $10 | $3.9K |